Differences Found in Smokers, Nonsmokers Who Develop NSCLC

Share this content:
Differences Found in Smokers, Nonsmokers Who Develop NSCLC
Differences Found in Smokers, Nonsmokers Who Develop NSCLC

THURSDAY, Oct. 1, 2015 (HealthDay News) -- A new study has identified significant differences between non-small-cell lung cancer patients who smoke and those who don't. The findings were presented Sunday at the annual meeting of the European Respiratory Society, held from Sept. 26 to 30 in Amsterdam.

Investigators compared 1,411 Portuguese patients with non-small-cell lung cancer and found that nonsmokers were more likely than smokers to be women and to have adenocarcinoma. The nonsmokers were also less likely to have chronic obstructive pulmonary disease, ischemic heart disease, previous cancer of the larynx, or weight loss.

In addition, nonsmokers lived about twice as long after diagnosis, an average of 51 months compared to 25 months for smokers. Many of the nonsmokers were diagnosed at an advanced stage of disease, including 59 percent at stage IV.

"We believe that the differences we found between the two groups will help improve diagnosis, and prompt investigators to try to find out why these differences occur," study author Catia Saraiva, M.D., of the Portuguese Institute of Oncology in Lisbon, said in a European Lung Foundation news release. "In the nonsmoking group, we found professional exposure to carcinogens in 9 percent, a family history of lung cancer in 5 percent, and a previous cancer diagnosis in 6 percent. Additionally, 18 percent had high blood pressure."

Abstract No. 4278
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »